Showing 321-330 of 3844 results for "".
Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Snapshot: The Percentage of Dermatology Offices Open During the COVID-19 Pandemic
https://practicaldermatology.com/topics/practice-management/snapshot-the-percentage-of-dermatology-offices-open-during-the-covid-19-pandemic/23404/A survey of practices in two states sheds light on the impact of the novel coronavirus.Three's the Charm
https://practicaldermatology.com/topics/practice-management/threes-the-charm/20585/Expert injectors discuss the promise and perils of Botox Cosmetic's third nod.Taking It On The Chin: Kybella vs. CoolSculpting for Reduction of Submental Fat
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/taking-it-on-the-chin-kybella-vs-coolsculpting-for-reduction-of-submental-fat/20686/At least two noninvasive modalities that specifically target double chins can be used alone or together.2014 Fourth Quarter Tax Saving Tips
https://practicaldermatology.com/topics/practice-management/2014-fourth-quarter-tax-saving-tips/21294/What to do now to save $10,000-$25,000 or more on your 2014 taxes.PV-10: Update on an Emerging Melanoma Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pv-10-update-on-an-emerging-melanoma-therapy/22971/Last year, Practical Dermatology reviewed data for an intralesional therapy for melanoma. Now a phase III trial appears imminent.Take 5: Recent Developments in Systemic Therapy for Psoriasis
https://practicaldermatology.com/columns/recent-developments/take-5-recent-developments-in-systemic-therapy-for-psoriasis/22002/New data reveal noteworthy financial and clinical trends in the use of systemic agents.A New Era in Hidradenitis Suppurativa Care
https://practicaldermatology.com/topics/rare-disease/a-new-era-in-hidradenitis-suppurativa-care/56428/Remarkable innovation is happening in HS. Ultimately, it comes down to this: we are now able to provide patients with a level of care that was not previously possible because so many new therapies are being unlocked.Comorbidities in Alopecia Areata
https://practicaldermatology.com/issues/july-2025/comorbidities-in-alopecia-areata/36507/Alopecia areata (AA) is a chronic, relapsing immune-mediated disorder that causes nonscarring hair loss that can significantly impact a patient’s quality of life.The Next Frontier: Device-Based Erectile Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-next-frontier-device-based-erectile-rejuvenation/20828/Low-intensity cutaneous shockwave treatment represents a novel option for the treatment of vasculogenic ED.